CIK 0001855129 · Accelerated filer<br>Emerging growth company
GH Research PLC
Sign in to watch- Ticker
- GHRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- other
- Phone
- 353 1 437 8334
- Business address
- JOSHUA DAWSON HOUSE, DAWSON STREET, DUBLIN 2, Ireland, D02 RY95
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-08 | Schonharting Florian Director | Grant or award · Share Options (Right to Buy) | +2,303 | 2,303 | ||
| 2026-08-11 | Moore Duncan Director | Grant or award · Share Options (Right to Buy) | +2,202 | 2,202 | ||
| 2026-08-11 | Hanley Dermot John Director | Grant or award · Share Options (Right to Buy) | +2,202 | 2,202 | ||
| 2026-08-11 | Forer Michael Director | Grant or award · Share Options (Right to Buy) | +2,202 | 2,202 | ||
| 2026-08-11 | Forer Michael Director | Grant or award · Share Options (Right to Buy) | +100,000 | 100,000 |
Page 1 of 1 · 5 trades